WNY1613

Modify Date: 2024-01-14 17:11:11

WNY1613 Structure
WNY1613 structure
Common Name WNY1613
CAS Number 2650546-39-5 Molecular Weight 557.65
Density N/A Boiling Point N/A
Molecular Formula C29H35N9O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of WNY1613


WNY1613 is a potent and selective PI3Kδ inhibitor with piperazinone-containing purine scaffold. WNY1613 induces cancer cell apoptosis and inhibits the phosphorylation of PI3K downstream components in NHL cell lines. WNY1613 exhibits anti-NHL activity in vitro and in vivo[1].

 Names

Name WNY1613

 WNY1613 Biological Activity

Description WNY1613 is a potent and selective PI3Kδ inhibitor with piperazinone-containing purine scaffold. WNY1613 induces cancer cell apoptosis and inhibits the phosphorylation of PI3K downstream components in NHL cell lines. WNY1613 exhibits anti-NHL activity in vitro and in vivo[1].
Related Catalog
References

[1]. Zuo WQ, et al. Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma. Bioorg Chem. 2020;105:104344.

 Chemical & Physical Properties

Molecular Formula C29H35N9O3
Molecular Weight 557.65
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.